The effect of Deluxitine on the negative symptoms of schizophrenia
Not Applicable
- Conditions
- egative symptom.
- Registration Number
- IRCT20191218045795N2
- Lead Sponsor
- Sanandaj University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 44
Inclusion Criteria
Patients with schizophrenia
Patients with prominent negative symptoms
Exclusion Criteria
major depression
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of the positive and negative symptoms of schizophrenia. Timepoint: At baseline, 2, 4 and 8 weeks later. Method of measurement: Questionnaire for comparing positive and negative symptoms.
- Secondary Outcome Measures
Name Time Method